Title
Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis
Author
Tornincasa, V.
Dixon, V.
Le Masne, Q.
Martin, B.
Arnaud, L.
van Dommelen, P.
Koledova, E.
Publication year
2022
Abstract
Digital health has seen rapid advancements over the last few years in helping patients and their healthcare professionals better manage treatment for a variety of illnesses, including growth hormone (GH) therapy for growth disorders in children and adolescents. For children and adolescents requiring such therapy, as well as for their parents, the treatment is longitudinal and often involves daily injections plus close progress monitoring; a sometimes daunting task when young children are involved. Here, we describe our experience in offering devices and digital health tools to support GH therapy across some 40 countries. We also discuss how this ecosystem of care has evolved over the years based on learnings and advances in technology. Finally, we offer a glimpse of future planned enhancements and directions for digital health to play a bigger role in better managing conditions treated with GH therapy, as well as model development for adherence prediction. The continued aim of these technologies is to improve clinical decision making and support for GH-treated patients, leading to better outcomes.
Subject
Growth
Disorders
Pediatric
Patients
Hormone
Therapy
To reference this document use:
http://resolver.tudelft.nl/uuid:0e2f64b7-f559-4496-b161-d713d3271f5b
DOI
https://doi.org/10.3389/fendo.2022.882192
TNO identifier
972405
Source
Frontiers in Endocrinology, 13 (13)
Document type
article